Sabra Healthcare REIT
SBRA
332 hedge funds and large institutions have $2.85B invested in Sabra Healthcare REIT in 2022 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 122 increasing their positions, 103 reducing their positions, and 34 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
38% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 34
18% more call options, than puts
Call options by funds: $5.51M | Put options by funds: $4.65M
18% more repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 103
2% more ownership
Funds ownership: 86.25% → 88.26% (+2%)
2% more funds holding
Funds holding: 326 → 332 (+6)
4% less capital invested
Capital invested by funds: $2.96B → $2.85B (-$112M)
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$64M |
| 2 |
JP Morgan Chase
New York
|
-$16.6M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$16.3M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$10.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.59M |
SBRA Hedge Fund Activity: Q2 2022 in Review
332 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q2 2022, worth a combined $2.85B — down 3.8% from $2.96B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new SBRA positions and 34 closed out — a net gain of 13 holders — while 122 added to existing stakes and 103 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $42.1M. The largest seller was Goldman Sachs, cutting an estimated $64M.
- 332 institutional investors held Sabra Healthcare REIT (SBRA) as of Q2 2022, up from 326 in Q1 2022.
- Funds reported $2.85B of Sabra Healthcare REIT stock for Q2 2022, down 3.8% quarter-over-quarter.
- 47 funds opened new Sabra Healthcare REIT positions in Q2 2022 and 34 closed out, a net change of +13 holders.
- The largest Sabra Healthcare REIT buyer in Q2 2022 was Deutsche Bank, an estimated $42.1M added.
- The largest Sabra Healthcare REIT seller in Q2 2022 was Goldman Sachs, an estimated $64M sold.
Based on aggregated 13F filings for Q2 2022.